Figure 2 from Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. | Semantic Scholar
Quantification of Infectious SARS-CoV-2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay | SpringerLink
Timeless TCID50: One solution to many viruses | VIROLOGY RESEARCH SERVICES
BioTek Applications: Virology TCID50
Median Tissue Culture Infective Dose (TCID 50 ) of Influenza Virus... | Download Table
Viruses | Free Full-Text | Optimized Hepatitis E Virus (HEV) Culture and Its Application to Measurements of HEV Infectivity
Quantification of Infectious SARS-CoV-2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay | SpringerLink
Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples | Scientific Reports
Infectivity of severe acute respiratory syndrome coronavirus 2 in children compared with adults | CMAJ
TCID50 Viral Clearance Studies - BioProcess InternationalBioProcess International
Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. | Semantic Scholar
Frontiers | Analytical Performance of Quantitative DiaSorin Liaison SARS-COV-2 Antigen Test for the Asymptomatic Population
Self-amplifying mRNA SARS-CoV-2 vaccines raise cross-reactive immune response to variants and prevent infection in animal models: Molecular Therapy - Methods & Clinical Development
Virucidal activity of antiseptic mouthwash and dental gel | CCIDE
The Tissue Culture Infectious Dose50 (TCID50) and the Plaque Assay - Fraunhofer IGB
Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity - ScienceDirect
Examination of viraemia and clinical signs after challenge with a heterologous PRRSV strain in PRRS Type 2 MLV vaccinated pigs: A challenge- dose study | PLOS ONE